Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/25/2017 |
| Start Date: | November 2009 |
| End Date: | December 2010 |
Efficacy if Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis
The purpose of this study is to identify patients with cardiac sarcoidosis who may be at risk
for sudden death.
for sudden death.
Sarcoidosis is an inflammatory disease that can effect many organ systems. Patients with
sarcoidosis involving the heart are at risk of sudden death related to ventricular
arrythmias. However, we currently do not have a clinical test which can predict sudden
cardiac death in these patients. While implantable cardioverter defibrillators(ICDs) can
prevent sudden cardiac death in high risk patients, we do not know which patients will
benefit from implantation of these devices. This clinical problem is important because we
would like to identify patients at risk for sudden death who will benefit from ICD
implantation. Additionally, we would like to avoid the risks to patients and financial
expenses of inserting ICDs in patients who will not benefit from them.
sarcoidosis involving the heart are at risk of sudden death related to ventricular
arrythmias. However, we currently do not have a clinical test which can predict sudden
cardiac death in these patients. While implantable cardioverter defibrillators(ICDs) can
prevent sudden cardiac death in high risk patients, we do not know which patients will
benefit from implantation of these devices. This clinical problem is important because we
would like to identify patients at risk for sudden death who will benefit from ICD
implantation. Additionally, we would like to avoid the risks to patients and financial
expenses of inserting ICDs in patients who will not benefit from them.
Inclusion Criteria:
- Diagnosis of Cardiac Sarcoidosis
- Previous Implantable Cardioverter Defibrillator (ICD)
We found this trial at
1
site
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
Click here to add this to my saved trials
